Naohide Hakushi - Daicel Executive Officer, Ohtake Plant Manager
Executive
Naohide Hakushi is Executive Officer, Ohtake Plant Manager of Daicel since 2018.
| Tenure | 7 years |
| Phone | 81 6 7639 7171 |
| Web | https://www.daicel.com |
Daicel Management Efficiency
The company has return on total asset (ROA) of 0.0417 % which means that it generated a profit of $0.0417 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.137 %, meaning that it generated $0.137 on every $100 dollars invested by stockholders. Daicel's management efficiency ratios could be used to measure how well Daicel manages its routine affairs as well as how well it operates its assets and liabilities.Daicel has accumulated 236.03 B in total debt with debt to equity ratio (D/E) of 1.0, which is about average as compared to similar companies. Daicel has a current ratio of 2.29, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Daicel until it has trouble settling it off, either with new capital or with free cash flow. So, Daicel's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Daicel sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Daicel to invest in growth at high rates of return. When we think about Daicel's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| David Ostro | Parker Hannifin | N/A | |
| Chad Yeftich | ioneer Ltd American | N/A | |
| Valerie JD | Cytek Biosciences | 50 | |
| Patrik Jeanmonod | Cytek Biosciences | 58 | |
| Mark Elrod | Avadel Pharmaceuticals PLC | N/A | |
| Rodolfo Musso | Cementos Pacasmayo SAA | 67 | |
| John Steele | Barrick Gold Corp | 59 | |
| Alfredo Lam | Cementos Pacasmayo SAA | N/A | |
| Matt Weaver | ioneer Ltd American | 59 | |
| Philippe Busque | Cytek Biosciences | 54 | |
| Dante Roncal | Cementos Pacasmayo SAA | 45 | |
| Kenneth Gaglione | Hudson Technologies | 63 | |
| Rodney Quick | Barrick Gold Corp | 48 | |
| Sebastiaan Bock | Barrick Gold Corp | 46 | |
| Rousseau Jooste | Barrick Gold Corp | N/A | |
| Brian Bertaux | Hudson Technologies | 55 | |
| Tito Mantero | Cementos Pacasmayo SAA | 53 | |
| Jerome II | Viemed Healthcare | 54 | |
| Diego Pazos | Cementos Pacasmayo SAA | 47 | |
| Yoshio Nagai | ioneer Ltd American | 63 | |
| Jennifer PharmD | Avadel Pharmaceuticals PLC | N/A | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0417 |
Daicel Leadership Team
Elected by the shareholders, the Daicel's board of directors comprises two types of representatives: Daicel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Daicel. The board's role is to monitor Daicel's management team and ensure that shareholders' interests are well served. Daicel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Daicel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kotaro Sugimoto, Executive Officer, Representative Director and President of Subsidiary | ||
| Dieter Heckmann, Executive Officer and Presidentident of Subsidiaries | ||
| Naotaka Kawaguchi, Executive Officer, Assistant Manager of Aerospace & Defense Systems/Safety Systems Company, Harima Plant Manager in Aerospace & Defense Systems/Safety Systems Company | ||
| Yoshimi Ogawa, Executive Officer, Manager of Production Technology Office, Director | ||
| Akihisa Takabe, Executive Officer, Deputy Chief Director of Research & Development | ||
| Takashi Ueno, Executive Officer, Arai Plant Manager and Presidentident of Subsidiary | ||
| Hidekage Kojima, Executive Officer, Manager of General Planning Office | ||
| Naohide Hakushi, Executive Officer, Ohtake Plant Manager | ||
| Ikuo Takahashi, Executive Officer, Manager of Innovation Park Center, Manager of Corporate Research Center in Main Research & Development Unit | ||
| Yasuhiro Sakaki, Executive Officer, Manager of Organic Synthesis Company |
Daicel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Daicel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0417 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 3.6 B | |||
| Shares Outstanding | 291.55 M | |||
| Shares Owned By Insiders | 5.30 % | |||
| Shares Owned By Institutions | 57.27 % | |||
| Price To Earning | 17.64 X | |||
| Price To Book | 0.90 X |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Daicel Pink Sheet
If you are still planning to invest in Daicel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Daicel's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |